Market closedNon-fractional

OptimizeRx/OPRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About OptimizeRx

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Ticker

OPRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Technology

Headquarters

Waltham, United States

Employees

136

OptimizeRx Metrics

BasicAdvanced
$183M
Market cap
-
P/E ratio
-$1.05
EPS
1.05
Beta
-
Dividend rate
$183M
1.05
2.884
2.741
26.708
29.754
-3.73%
-4.54%
-14.66%
2.224
1.51
-42.94
-29.801
26.71%
30.88%
18.54%
186.53%

What the Analysts think about OptimizeRx

Analyst Ratings

Majority rating from 7 analysts.
Buy

OptimizeRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-34.69% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$20M
-30.74%
Net income
-$6.8M
65.85%
Profit margin
-34.69%
139.57%

OptimizeRx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 13.73%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.01
$0.09
$0.26
-$0.11
-
Expected
-$0.02
$0.03
$0.32
-$0.13
-$0.05
Surprise
-53.33%
260.00%
-19.50%
-13.73%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for OptimizeRx stock?

OptimizeRx (OPRX) has a market cap of $183M as of July 06, 2024.

What is the P/E ratio for OptimizeRx stock?

The price to earnings (P/E) ratio for OptimizeRx (OPRX) stock is 0 as of July 06, 2024.

Does OptimizeRx stock pay dividends?

No, OptimizeRx (OPRX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next OptimizeRx dividend payment date?

OptimizeRx (OPRX) stock does not pay dividends to its shareholders.

What is the beta indicator for OptimizeRx?

OptimizeRx (OPRX) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell OptimizeRx stock

Buy or sell OptimizeRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing